Skip to main content

Corteva, Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

CTVA$12.17+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Non-GAAP Financial Measures

The company presents certain financial measures that do not conform to U.S. GAAP and are considered non-GAAP measures. These measures include Operating EBITDA and operating earnings (loss) per share. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the company and a more useful comparison of year over year results. These non-GAAP measures supplement the company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided below.

Operating EBITDA is defined as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and OPEB credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Operating earnings (loss) per share is defined as "earnings (loss) per common share from continuing operations - diluted" excluding the after-tax impact of significant items, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the company's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.

The company also uses Free Cash Flow as a non-GAAP measure to evaluate and discuss its liquidity position and ability to generate cash. Free Cash Flow is defined as cash provided by (used for) operating activities – continuing operations, less capital expenditures. Management believes that Free Cash Flow provides investors with meaningful information regarding the company’s ongoing ability to generate cash through core operations, and the company’s ability to service its indebtedness, pay dividends (when declared), make share repurchases, and meet its ongoing cash needs for its operations.

Reconciliation of Income (Loss) from Continuing Operations after Income Taxes to Operating EBITDA

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2025202420252024
Income (loss) from continuing operations after income taxes (GAAP)$1,382$1,056$2,049$1,432
Provision for (benefit from) income taxes on continuing operations422282539388
Income (loss) from continuing operations before income taxes (GAAP)$1,804$1,338$2,588$1,820
Depreciation and amortization301312597619
Interest income(31)(25)(63)(60)
Interest expense526688107
Exchange (gains) losses - net257852137
Non-operating (benefits) costs - net3301382
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges43(19)52(18)
Significant items (benefit) charge(33)13726264
Operating EBITDA (Non-GAAP)$2,164$1,917$3,353$2,951

Significant Items

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2025202420252024
Restructuring and asset related charges - net$(79)$(92)$(101)$(167)
Estimated settlement expense1—(47)—(101)
Inventory write-offs2—2—2
Gain (loss) on sale of assets2143147
Acquisition-related costs3—(3)—(5)
AltEn facility remediation charges4——(37)—
Insurance proceeds598—98—
Total pre-tax significant items benefit (charge)$33$(137)$(26)$(264)
Total tax (provision) benefit impact of significant items6(6)34866
Tax only significant item benefit (charge)7——55—
Total significant items benefit (charge), after tax$27$(103)$37$(198)
  1. Consists of estimated Lorsban® related charges.

  2. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. For additional information, refer to Note 6 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, in the company's 2024 Annual Report.

  3. Relates to acquisition-related costs relating to third-party integration costs associated with the completed acquisitions of Stoller and Symborg.

  4. Relates to a charge to increase the remediation accrual at the AltEn facility relating to Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans. See Note 12 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information.

  5. Includes proceeds received related to prior significant items.

  6. Unless specifically addressed above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

  7. The tax only significant item benefit for the six months ended June 30, 2025 reflects a deferred tax benefit associated with a change in a legal entity's U.S. tax characterization.

Reconciliation of Income (Loss) from Continuing Operations Attributable to Corteva and Earnings (Loss) Per Share of Common Stock from Continuing Operations - Diluted to Operating Earnings (Loss) and Operating Earnings (Loss) Per Share

Three Months Ended June 30,Six Months Ended June 30,
(In millions)2025202420252024
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP)$1,380$1,053$2,043$1,425
Less: Non-operating benefits (costs), after tax(8)(21)(16)(61)
Less: Amortization of intangibles (existing as of Separation), after tax(110)(118)(219)(235)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax(33)15(40)14
Less: Significant items benefit (charge), after tax27(103)37(198)
Operating Earnings (Loss) (Non-GAAP)$1,504$1,280$2,281$1,905
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Earnings (loss) per share of common stock from continuing operations attributable to Corteva common stockholders - diluted (GAAP)$2.02$1.51$2.98$2.03
Less: Non-operating benefits (costs), after tax(0.01)(0.03)(0.02)(0.09)
Less: Amortization of intangibles (existing as of Separation), after tax(0.16)(0.16)(0.32)(0.34)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax(0.05)0.02(0.06)0.02
Less: Significant items benefit (charge), after tax0.04(0.15)0.05(0.28)
Operating Earnings (Loss) Per Share (Non-GAAP)$2.20$1.83$3.33$2.72
Diluted Shares Outstanding (In millions)683.1698.1684.7700.4
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.